Lunaphore is developing the next-generation spatial biology platform for immuno-oncology research and diagnostics. Based on a proprietary microfluidic chip technology, Lunaphore’s fullstack platform offers customers unprecedented speed, throughput and flexibility in tissue analytics meeting today‚Äôs needs, where medicine is becoming more personalized and whole panels of biomarkers play an increasing role.